In the News

Recent Coverage of HMS in the News
December 2, 2013

In a new study, researchers chip away again at the traditional view of carbon monoxide as a menace. They found that administering carbon monoxide to cancer cells in a dish could increase the cells’ susceptibility to chemotherapy 1,000-fold, while protecting normal cells. In mice with prostate and lung cancer, carbon monoxide inhibited tumor growth. Leo Otterbein, HMS associate professor of surgery at Beth Israel Deaconess Medical Center, led the research.

December 2, 2013

Until now, there’s been little medical guidance to help cancer patients find foods they can tolerate and maintain a healthy weight. Julie Silver, HMS associate professor of physical medicine and rehabilitation at Spaulding Rehabilitation Hospital, is quoted.

December 1, 2013

Scientists who dared to waste their time looking at the midbody, a remnant of cell division, have catapulted the organelle to new prominence. Tim Mitchison, the Hasib Sabbagh Professor of Systems Biology and deputy chairman of the Department of Systems Biology at HMS, is quoted.

December 1, 2013

Prayer and belief that God has a plan could lead to better outcomes for psychiatric illness patients receiving short-term treatment, a small new study suggests. David H. Rosmarin, HMS instructor in psychology in the Department of Psychiatry at McLean Hospital, is the lead investigator.

November 30, 2013

A group of researchers has recently identified the first targeted therapy for a specific type of kidney disease, focal segmental glomerulosclerosis, or FSGS. Peter H. Mundel, HMS associate professor of medicine at Massachusetts General Hospital, led the team.

November 28, 2013

The days of scrawled doctor’s notes are slowly coming to a close. In the United States, 93 percent of hospitals are now using at least some electronic medical records and 2.2 percent have given up paper records completely, according to a new report. Robert C. Green, HMS associate professor of medicine at Brigham and Women’s Hospital and Daniel MacArthur, HMS assistant professor of medicine at Massachusetts General Hospital, are quoted.

November 25, 2013

A new Cambridge life-science company aims to develop therapies that can put troublesome genes under the knife, so to speak, cutting out bad DNA like a scalpel excises bad tissue. Cofounders of the company include George Church, HMS professor of genetics and member of the Wyss Institute, and Keith Joung, director of the molecular pathology unit at Massachusetts General Hospital.

November 22, 2013

While doctors routinely perform vitamin D blood tests during annual physicals, many of the 70 to 90 percent of African Americans who are diagnosed as vitamin D deficient may actually have healthy levels and could be taking supplements unnecessarily. Ravi Thadhani, HMS
professor of medicine at Massachusetts General Hospital, is the senior author of the study.

Pages

Resources

Submit Photo Requests to HMS
To request photos from the HMS Office of Communications and External Relations, click here.

 

Tell us about your awards
Share news of your achievements with the larger HMS community, click here.

 

Book Reviews
If you are a faculty member who has published a book recently, click here.